Cancer Treater's IPO Nets $102M; Device Maker Reduces Plans
The initial public offering market continued its sluggish pace Thursday as glucose monitoring device maker Senseonics downsized its IPO by $15 million, a day after Chinese cancer treatment company Hutchison China...To view the full article, register now.
Already a subscriber? Click here to view full article